Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

The anti-obesity drug boom may be cooling, as overall prescribing of GLP-1 medicines remained relatively flat for the three ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

The states with the highest obesity rates were found throughout the Plains, the South, and into the Midwest, while coastal ...

Telehealth companies that have seized on the boom in weight loss drugs are playing a bigger role not just in treating ...

It is not often that public health news comes with a silver lining, but new data on obesity rates in the US does just that: ...

Researchers at Mass General Brigham examined a new way to define obesity that goes beyond BMI by also considering how body fat is distributed. Obesity rates in the United States may increase dramatica ...

Many areas in West Virginia are medically underserved, limiting access to prevention and treatment. Nutrition, physical ...

Eli Lilly and Company is a Strong Buy due to strong growth in obesity and diabetes drugs and pipeline innovation. Learn more ...

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped.

Ozempic's rise as a weight-loss drug has been nothing short of explosive. Now, a new implant version for pets is set to be ...

Obesity has now reached pandemic proportions.1,2 WHO coined the term globesity to characterise its relentless rise worldwide ...